Personalized medicine in diabetes: the role of 'omics' and biomarkers - Wikidata - awgldk - TriplyDB

Personalized medicine in diabetes: the role of 'omics' and biomarkers

Personalized medicine in diabetes: the role of 'omics' and biomarkers

http://www.wikidata.org/entity/Q26775259

about

Metabolomics: Bridging the Gap between Pharmaceutical Development and Population Health Effects of dietary restriction on adipose mass and biomarkers of healthy aging in human.PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease.Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.Cancer subtypes in aetiological research.Precision medicine in diabetes prevention, classification and management.The economic case for precision medicine.

P2860

Q26741270-D52E9C00-E7BE-416C-BAD0-750AA435456F Q37610197-6DBAB4C9-1312-4884-ADE3-63CF097327B0 Q37718557-B564DFE7-960F-4844-8CAB-FB92F0405714 Q39040207-FAF16CFF-68DC-409C-8A14-A3D3305D387D Q39397286-B08E661E-F9BC-414D-9C6C-EF4A5E661CBF Q52677048-71CF900F-C494-423C-BBED-0239ED9FAD2C Q55217201-EC04D110-13BA-4E9C-B060-88516C9A7AAF

P2860

Personalized medicine in diabetes: the role of 'omics' and biomarkers

http://www.wikidata.org/entity/Q26775259

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Personalized medicine in diabetes: the role of 'omics' and biomarkers

@ast

Personalized medicine in diabetes: the role of 'omics' and biomarkers

@en

Personalized medicine in diabetes: the role of 'omics' and biomarkers

@nl

type

label

Personalized medicine in diabetes: the role of 'omics' and biomarkers

@ast

Personalized medicine in diabetes: the role of 'omics' and biomarkers

@en

Personalized medicine in diabetes: the role of 'omics' and biomarkers

@nl

prefLabel

Personalized medicine in diabetes: the role of 'omics' and biomarkers

@ast

Personalized medicine in diabetes: the role of 'omics' and biomarkers

@en

Personalized medicine in diabetes: the role of 'omics' and biomarkers

@nl

P1433

Q26775259-41B6E7AF-593E-4723-8C63-DBEC685DCE33

P1476

Q26775259-07A6B162-E5A8-4237-9B8D-99E9BF24F2AD

P2093

Q26775259-9483DD9D-6821-4719-AE91-C87225937B04

P275

Q26775259-0AE96DB2-63FF-4F6C-BCC1-A71DD20B832D

P2860

Q26775259-001D1D1C-19D6-4BE7-A501-2EF2E533D908

Q26775259-080DB576-D80D-436E-B205-F81F9E64B866

Q26775259-0B4E51D8-8B78-44B3-BC4E-E8E414E8890E

Q26775259-24D50300-2331-400A-9CB3-6478C7E9B26B

Q26775259-2C7D8EB4-A4C8-4CE2-983B-3A7D210A9AC7

Q26775259-3B1C71AC-5D05-4E6F-B169-8C760C145973

Q26775259-49F3C209-E773-4DD7-8B11-71EF3D2070D9

Q26775259-4EC202A2-B7FD-47B7-9235-826784EC188F

Q26775259-52B4987B-CEED-4987-A6B0-A5405DFE1CE1

Q26775259-5508CE5E-1704-47CD-99C2-7DC77F2A0614

P304

Q26775259-4D8B7DC7-1A39-466F-8BD1-B95E94732E80

P31

Q26775259-8580A3FA-6E4B-4697-AF39-9724B415145C

Q26775259-E1AB5951-BFDB-4FAC-A45D-094A6DF29554

P3181

Q26775259-95D49EDD-895B-49C8-A66C-8B6FE2308894

P356

Q26775259-7C3379CE-979F-46DE-B735-A51A5ED5D1EB

P407

Q26775259-C794CFC8-F65E-4AEC-B5AF-C474E71FB217

P433

Q26775259-3E9A4DCB-E03F-44C4-9607-0D7C9616B838

P478

Q26775259-9DD7038B-5194-4806-8B07-2D96C29B8699

P50

Q26775259-1A17FF69-D52A-493C-A4AD-223B94B52E7D

P5008

Q26775259-32D8304D-1B4A-4CED-A8BB-F9BE85AEDA15

P577

Q26775259-710FC06F-EA66-436E-B1F0-A65282783BE1

Q26775259-98393064-950C-4274-8290-DE00DE0398D6

P698

Q26775259-3EA976B9-97F7-45E1-B00C-778A9AB7B314

P921

Q26775259-BDFE5E0E-2807-46C5-825E-A99FD6E3219B

Q26775259-F64292AF-B0E6-46D7-A2DF-B6CB84158AB0

Q26775259-FB107D8D-8EDF-4D94-BB70-391D39BD74D6

Q26775259-FFC37674-039D-4651-AE37-66EB0AE42B48

P932

Q26775259-FF146E74-C56E-42EC-A4A3-968C394B022E

P3181

P356

P1433

Diabetic Medicine

P1476

Personalized medicine in diabetes: the role of 'omics' and biomarkers

@en

P2093

E R Pearson

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Metformin and the gastrointestinal tract

Genetic cause of hyperglycaemia and response to treatment in diabetes

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis.

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes

Cometabolism of microbes and host: implications for drug metabolism and drug-induced toxicity.

Addition of a Gastrointestinal Microbiome Modulator to Metformin Improves Metformin Tolerance and Fasting Glucose Levels

Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept.

Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study.

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

P304

712-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4606308

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/DME.13075

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26802434

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

type-2 diabetes

maturity-onset diabetes of the young

P932

4879510

http://www.w3.org/2001/XMLSchema#string